OBJECTIVE: To review the surgical outcome of the Yasui operation in patients with adequate-sized ventricles and ventricular septal defect (VSD) associated with obstructions of the aortic arch and left ventricular outflow tract (LVOT).
INTRODUCTION
The first report of primary biventricular repair by Yasui in 2 neonates with interrupted aortic arch (IAA) and severe left ventricular outflow tract obstruction (LVOTO) was in 1987 at our institution [1] . Since then, several modifications have been implemented [2] [3] [4] [5] [6] [7] , and satisfactory surgical results have been reported [8] [9] [10] [11] [12] . The utility of the Yasui operation has been well recognized; however, because of the complicated and extensive nature of this surgery, controversy exists regarding the surgical strategy of this procedure. Some leading institutions recommend primary repair in the neonatal period [9, 10] ; however, staged repair following an initial palliative procedure should be considered depending on the patient's condition [12] . In this study, we summarized our experience of the Yasui operation to assess the surgical outcome and efficacy of the staged strategy.
MATERIALS AND METHODS

Patients
From 1985 to 2012, 17 patients underwent the Yasui operation at Fukuoka Children's Hospital. The characteristics of the patients are summarized in Table 1 . Eleven patients had IAA, and 6 patients had coarctation of the aorta (CoA) or hypoplastic arch. Among the types of LVOTO, aortic atresia was present in 5 patients and aortic valvular stenosis and/or subaortic stenosis was observed in 12 patients. The cardiac anatomy was ventricular septal defect (VSD) in 9 patients, double outlet right ventricle (DORV) in 7 patients and double outlet left ventricle (DOLV) in 1 patient. The type of VSD was perimembranous outlet in 9 patients, including inlet extension in 3 patients, subarterial in 7 patients and muscular outlet in 1 patient. Five patients had chromosomal abnormalities, including CHARGE syndrome in 3 patients and the 22q11.2 deletion syndrome in 2 patients. The echocardiographic measurements taken before the Yasui operation showed that the mean minimum left ventricular outflow tract (LVOT) diameter was 3.7 ± 0.4 mm (range, 3.0-4.4) and the mean z-score was −9.4 ± 1.2 (range, −11.7 to −8.3). The mean mitral annulus diameter was 14.1 ± 2.8 mm (range, 9.9-19.4) and the z-score was −0.2 ± 1.6 (range, −3.1 to 2.5). Prior to the Yasui operation in 11 patients, palliative surgery was performed, including bilateral pulmonary artery banding (PAB) in 8 patients, aortic arch repair with PAB in 2 patients and Norwood operation in 1 patient. The 2 patients who initially underwent aortic arch repair with PAB were patients with DORV (Taussig-Bing anomaly) with IAA, and DORV (subarterial VSD) with CoA, who were presented with severe congestive heart failure. We decided to perform a staged biventricular repair; however, subaortic stenosis developed after the initial operation, which made them candidates for the Yasui operation. In the staged group, age and body weight of the patients at the time of palliative surgery were 12. 
Operation
Cardiopulmonary bypass technique. During the aortic arch reconstruction in our earlier series, 33 min of deep hypothermic circulatory arrest was used in 1 patient, and a short period (18, 19 and 22 min) of cerebral circulatory arrest was employed in 3 patients using the revised perfusion technique developed at our institution [13] . In the last 13 cases from 2003, the total body perfusion technique was employed to avoid circulatory arrest during arch reconstruction [14] . Briefly, by inserting another arterial cannula to the descending thoracic aorta through the posterior pericardium for lower body perfusion in addition to selective cerebral perfusion, mild hypothermic high-flow total body perfusion was maintained throughout the operation.
Aortic reconstruction. In the first 2 patients in this series, the interrupted arch was repaired by the interposition of polytetrafluoroethylene (PTFE) graft (8 mm in 1 patient and 6 mm in the other patient) from the ascending aorta to the descending aorta in addition to Dames-Kaye-Stansel (DKS) connection between the proximal pulmonary trunk and the ascending aorta. Of the remaining 15 patients, proximal DKS connection combined with direct arch anastomosis was performed in 6 patients, and Norwood-type reconstruction was performed in 9 patients.
Intraventricular rerouting. A longitudinal incision was made approximately 10 mm beneath the pulmonary annulus on the right ventricular outflow tract, rather than on the body of the right ventricle. Intraventricular baffling can be performed through this RV outflow incision when the type of VSD is perimembranous outlet, subarterial or muscular outlet. The lower part of the VSD is closed through the right atrium when the VSD extends towards the inlet. We are extremely careful to ensure that the incision is not close to the left anterior descending artery. A Dacron patch (n = 4) or PTFE patch (n = 13) was used to baffle the left ventricular outflow through the VSD to the pulmonary and aortic valves in patients with aortic stenosis or to the pulmonary valve in patients with aortic atresia. The VSD was enlarged anterolaterally in 6 patients.
Right ventricle to pulmonary artery connection. A RV to pulmonary artery (PA) connection was established using a valved conduit in 14 patients (Hancock 14 mm in 2 patients, Carpenter-Edwards 12 mm in 1 patient, a handmade valved conduit from the xenopericardium in 1 patient and a handmade PTFE valved conduit [15] in 10 patients [10 mm in 1 patient, 12 mm in 7 patients, 14 mm in 1 patient, and 16 mm in 1 patient]). The right ventricular outflow tract reconstruction (RVOTR) was performed by direct posterior anastomosis with an anterior monocusp patch in 1 patient, and the Lecompte manoeuvre [6, 7] was employed in 2 patients.
The mean duration of cardiopulmonary bypass and myocardial ischaemia were 330.5 ± 79.8 min and 135.2 ± 23.2 min, respectively. Sternal closure was possible in 4 of 6 patients in the primary group and 9 of 11 patients in the staged group. The perioperative data are summarized in Table 2 .
Statistical analysis
All data were expressed as mean ± standard deviation. Actuarial survival and freedom from reoperation were calculated using the Kaplan-Meier formula.
RESULTS
There was no interstage death after the initial palliation in the staged group. After the Yasui operation, 1 patient required extracorporeal membrane oxygenation (ECMO) due to severe ventricular dysfunction. The patient was successfully weaned off ECMO 5 days later. Operative death occurred in 1 patient. The patient was a 3.2 kg neonate with a diagnosis of aortic atresia with VSD associated with CoA. The patient underwent a primary Yasui operation at the age of 20 days. The ascending aorta was 1.5 mm in diameter, and Norwood-type aortic reconstruction using a xenopericardial roll was performed. Acute haemodynamic deterioration occurred immediately after admission to the intensive care unit (ICU). Autopsy confirmed the acute myocardial infarction. There was 1 late death, 11 months after the operation, where the patient died of acute viral encephalitis. The haemodynamic status of the patient had been stable. The actuarial survival at 10 years was 87.8% in the entire group (Fig. 1 ).
Reoperation
Six patients underwent 8 reoperations, including 13 procedures (Table 3) . Six RVOTRs (RV-PA conduit exchange in 5 patients and anterior monocusp patch in 1 patient) were performed 5.3 ± 2.5 years after the Yasui operation. Two procedures for recurrent LVOTO were performed. The first patient originally had a perimembranous outlet with inlet extension VSD with an accessory mitral valve. At the time of the Yasui operation, the accessory mitral valve was resected, and the VSD was enlarged, and a long intraventricular route using a PTFE patch was created. The patient developed recurrent LVOTO and mitral regurgitation and underwent redo-intraventricular baffling with concomitant mitral valve repair using PTFE artificial chordae at 28 months after the Yasui operation. The other patient developed discrete fibrous stenosis at the subaortic area and underwent resection of the subaortic fibrous tissue with VSD enlargement after 42 months. The first 2 patients who had an interposing PTFE graft between the ascending and descending aorta required reoperation for a significant pressure gradient. In the first patient with an 8 mm graft, another graft interposition between the left common carotid artery and descending aorta with a 12-mm PTFE graft was performed 7.8 years after the primary Yasui operation. The second patient underwent replacement of the 6-mm interposing graft with an 18-mm graft 8.7 years later. Two procedures for the branch pulmonary artery (resection of the fibrous ridge in 1 patient and PTFE graft interposition to the left pulmonary artery in 1 patient who underwent the Lecompte manoeuvre) were performed concomitantly with RVOTR. The first patient in our series underwent a second RV-PA conduit exchange. The freedom from reoperation for all causes at 5 and 10 years in our series were 71.3 and 28.5%, respectively, and 81.5 and 48.9% for reoperation excluding the RV-PA conduit exchange (Fig. 2) .
Postoperative course
In the staged group, 5 patients were extubated within 24 h after the Yasui operation. Excluding a patient who required ECMO and another patient with multiple chromosomal disorder, the mean time to the extubation and the mean ICU stay were 1.9 ± 1.5 days (range, 0-5) and 5. 
Echocardiogram
The last postoperative cardiac echo study was performed in 16 patients at 5.6 ± 7.6 years after the Yasui operation. The left ventricular ejection fraction was 70.5 ± 12.1%, and the LVOT flow velocity was 1.2 ± 0.8 m/s (range, 0-3.9). The patient with an LVOT flow velocity of 3.9 m/s recurrently developed subaortic fibrous ridge after surgical resection in the reoperation as described above. The degree of regurgitation from the neoaortic valve (anatomical aortic valve or pulmonary valve) was absent in 11 patients, trivial in 5 patients, and mild in 1 patient. All survivors are in New York Heart Association Class I.
DISCUSSION
In the presence of a VSD with two adequate-sized ventricles, biventricular repair is possible in patients with severe LVOTO and arch obstruction. The first report of a successful primary biventricular repair in 2 neonates with IAA and severe aortic stenosis was performed by Yasui at our institution in 1987 [1] . Since then, the concept of the Yasui operation (a combination of integrated aortic arch reconstruction, redirection of LV outflow through the VSD to both the semilunar valves and establishment of RV-PA continuity using a valved conduit) has been applied for patients with aortic atresia and VSD with normal left ventricle [2, 3, 6] . Several modifications have been made in terms of the surgical technique. Aortic arch reconstruction may be performed by proximal anastomosis of the pulmonary trunk and the ascending aorta by means of DKS connection with direct repair of the obstructed arch or Norwood-type arch reconstruction with or without the use of a homograft [2] [3] [4] [5] [6] , depending on the individual anatomy. To establish RV-PA continuity, the Lecompte manoeuvre has been expected to reduce or delay the risk of reoperation in patients with a certain anatomy [6, 7] . The surgical results of the Yasui operation in a relatively small series of patients have been reported with satisfactory results. An early report by Ohye et al. [11] described their experience with 20 patients (11 underwent primary repair and 9 underwent staged repair) with a 5-year actuarial survival of 78%. Pearl et al. [12] reported the results of 8 patients (6 were staged with the initial Norwood operation) without early and late mortality. More recently, Kanter et al. [8] reported their experience of the Yasui operation in 21 patients (6 underwent primary repair and 15 underwent staged repair) with no early mortality, 3 late deaths and a 5-year actuarial survival of 75%. The result of the current study demonstrating an actuarial survival of 87.8% at 10 years is satisfactory for this group of patients with complex heart defects. The Yasui operation requires a valved conduit for RV-PA continuity; therefore, reoperation is frequently required.
The Yasui operation is indicated in patients with significant aortic valvular stenosis or subaortic stenosis that is unable to accommodate systemic output without a pressure gradient in the presence of a normal left ventricle and VSD. In determining the indication for the Yasui operation in terms of the severity of LVOTO, we set the minimum LVOT diameter of body weight plus 1 mm or less. For example, an LVOT diameter of <4 mm in a 3 kg patient, which is consistent with the recommendation by Kanter et al. [8] that the Yasui operation should be considered when the smallest diameter of the LVOT is <4 mm in neonate. In patients with an adequate-sized aortic annulus and a posteriorly malaligned conal septum as the main cause of LVOTO, simple patch closure of the VSD may result in a septal shift that increases the size of the outflow tract. However, the z-score of the minimum size of the LVOT in our series was −9.4 ± 1.2, and adequate increase in size through septal shift alone appear to be difficult. In contrast, Bove et al. [16] successfully relieved LVOTO via partial resection of the posteriorly malaligned conal septum in neonates with severe subaortic stenosis, VSD, and aortic arch obstruction who had a nearly normal-sized aortic annulus. Most of our patients displayed combined causes of LVOT stenosis, including aortic valve. Resection of the conal septum from the right atrium in neonates and infants has an inherent risk of aortic valve injury, and the risk of recurrence is possible. Therefore, resection of the conal septum is not attempted in this situation. For these reasons, we used the minimum diameter of LVOT, rather than the aortic annular diameter, as the indication for the Yasui operation. We believe that the use of the Yasui operation is not restricted by the type of VSD, although we believe that the design of the intraventricular baffle must be carefully determined in patients with inlet extension VSD.
The Ross-Konno procedure with concomitant arch repair and VSD closure is a possible alternative in this group of patients. The Ross-Konno operation in patients with critical aortic stenosis had been associated with good mid-term results; however, when arch obstruction is concomitantly present, the surgical results are not satisfactory. According to a large multi-institutional cohort study by the Society of Thoracic Surgeons Congenital Heart Surgery Database, among 30 patients younger than 1 year of age who underwent aortic valve replacement (Ross-Konno in 25 patients, Ross in 4 patients and homograft aortic valve replacement in 1 patient) with concurrent arch repair, the early mortality rate was 33% [17] . Similarly, Shinkawa et al. [18] reported that among 31 cases of the Ross/Ross-Konno operation in neonates and infants, 12 cases required concomitant arch repair, and early mortality occurred in 4 patients (33.3%). They both concluded that the Ross-Konno operation with concomitant arch surgery has higher operative risks. Another report regarding a modified Ross-Konno operation in 24 neonates and infants by Maeda et al. [19] reported good mid-term survival (95% at 5 years); however, the freedom from moderate or severe pulmonary autograft insufficiency was 74.5% at 5 years, and the overall freedom from surgical reintervention was 36.9% at 5 years. Thus, performing the Ross-Konno operation with concomitant arch repair in this subset of patients appears to carry the greater risks in terms of surgical mortality and pulmonary autograft dysfunction. Our results of the Yasui operation demonstrated an actuarial survival of 87.8% at 10 years, with good left ventricular function without outflow tract stenosis and neoaortic valve function (LVOT flow velocity of 1.2 ± 0.8 m/s, and absence of regurgitation from the neoaortic valve in 11 patients, trivial regurgitation in 5 patients and mild regurgitation in 1 patient). With the equivalent rate of postoperative reintervention, we believe that the Yasui operation is superior for this subset of patients.
Another point in favour of the Yasui operation is the technical difficulty in coronary harvesting and reimplantation in the RossKonno operation in patients with diminutive ascending aorta. When there is a large size discrepancy between the pulmonary and aortic annuli, reimplanted coronary arteries may end up in an unusual position, which could result in coronary insufficiency. Additionally, for patients with aortic atresia, the Yasui operation is the only option for biventricular repair.
Although the utility of the Yasui operation has been well recognized, it is still controversial whether this procedure should be performed as a primary repair in the neonatal period or as a staged repair after an initial, palliative procedure. The potential advantages of primary neonatal repair include early normalization of circulation. Gruber et al. [10] reported 21 cases of neonatal primary repair with no early mortality and 1 late death. Nathan et al. described 17 cases of primary neonatal repair for aortic atresia with severe LVOTO and reported 3 (18%) early mortalities with no late deaths. Their actuarial survival at 10 years was 82% [9] . With these good results, they advocated for primary neonatal repair in this group of patients.
In contrast, there is little evidence that a staged strategy carries a greater risk than primary neonatal repair. Ohye et al. [11] compared 11 cases of primary repair and 9 cases of staged repair following the initial Norwood procedure. The 5-year actuarial survival was 73% for the primary repair group and 89% for the staged group, and they did not find any significant differences in mortality or morbidity between the groups. Similarly, Kanter et al. [8] did not find a difference between the two strategies in terms of the surgical outcome. In our experience, the surgical results (1 operative death in the primary repair group in our early experience and 1 non-cardiac late death in the staged repair group) and the incidence of reoperation was similar between primary and staged groups; however, the postoperative course was more stable in the staged group.
The Norwood stage 1 operation had been the most widely performed initial palliation prior to the Yasui operation [8, 11, 12] . The most important concern for the staged approach with the Norwood procedure is that the patients have to spend months with a shunted single-ventricle physiology. Bilateral PAB has been recognized as an effective palliation in high-risk neonates, and we have extensive experience with bilateral PAB for hypoplastic left heart syndrome [20] or other types of arch obstruction with ductus-dependent systemic circulation. Freedom et al. [21] used bilateral PAB in conjunction with Pott's shunt in 1976, and in 1983, Duffy et al. [22] performed bilateral PAB with graft placement between the main pulmonary artery and the aortic isthmus in patients with aortic atresia with VSD. Of 11 patients with the staged group in our series, 8 patients were initially palliated with bilateral PAB prior to the Yasui operation and we found that this is a simple and very effective palliation to control congestive heart failure in symptomatic neonates. In addition, bilateral PAB is useful especially in patients with a marginal LVOT size, because we could delay the decision-making of whether to select the Yasui operation or the standard biventricular repair based on the timerelated change in the size of the LVOT. Bilateral PAB is less invasive than the Norwood procedure, and thus, it is a very useful initial palliative procedure for potential and absolute candidates for the Yasui operation. We believe that a body weight of 4 kg is sufficient to qualify for the Yasui operation and that 3 months is a sufficient interval to stabilize the pulmonary resistance and gain some weight before the Yasui operation. After stabilizing the circulation, some growth, and an increase in the size of the heart, the surgical indication is better determined, and the procedure could be performed more safely.
In conclusion, the Yasui operation can be performed in both primary and staged strategies with excellent results having low mortality and good mid-term left ventricular function for patients with adequate-sized ventricles with VSD associated with aortic arch obstruction and LVOTO. Bilateral PAB as the initial palliation is a safe and useful option in symptomatic neonates.
APPENDIX. CONFERENCE DISCUSSION
Dr R. Jonas (Washington, DC, USA): I think that an 88% 10-year survival is really remarkable for this challenging operation. Unfortunately, however, your total reoperation rate is quite high in that only one-third of patients were free of any reoperation by 10 years postoperatively. So I think it emphasizes to us that we have to be careful about which patients we choose for this operation. And I think we also need to look back at the results of the multi-institutional interrupted aortic arch study that was conducted by the Congenital Heart Surgeons' Society back in the mid '90s. Adding a Yasui-type procedure in that multiinstitutional study, not just institutions that really specialized in this operation, but across the spectrum of the Congenital Heart Surgeons' Society, increased the mortality risk quite substantially relative to doing a standard interrupted arch repair with VSD closure and leaving some degree of left ventricular outflow tract obstruction.
I think it can be difficult to know when the LV outflow tract is too small. You've given us your formula, but I'd like your comments, as my first question, as to whether you think it's possible that the conal septum can move from left to right when you close the VSD. Furthermore, the shape of the LV outflow tract is often elliptical. So if you simply take the minimum dimension in the long axis view, then you can be fooled into thinking that you have an unacceptable LV outflow tract, whereas the reality is with that elliptical shape and with just a half a millimetre of movement of the conal septum when you close the VSD, you can have an acceptable outflow tract. So my first question is: Just how aggressively should we be doing this Yasui operation?
Dr Nakano: Actually we have no idea how the conal septum will move after a standard repair with VSD patch closure, but some reports recommend to resect the conal septum through the right atrium. But we think that this is very risky because of the associated risk of intraoperative aortic injury. And preoperative echo, in any view, the minimum diameter of LV outflow tract less than body weight plus 1 mm, as I mentioned in the slide, we think this is an indication for a Yasui operation.
Dr Jonas: My second question relates to the issue of a one-stage versus a two-stage procedure for this operation. In your manuscript you suggested that since the results were similar with a one-stage versus a two-stage, you felt encouraged quite often to use a two-stage approach. I would say that our approach would be the opposite, that if we're going to get equivalent results with a one-stage approach, we would definitely always choose the onestage approach. I think that's a much kinder choice for our intensive care colleagues. I think it's much easier to manage a much more stable patient in the intensive care unit if you do a one-stage correction with a normal biventricular circulation.
I also have to say that what has helped us with a neonatal one-stage repair has been to use a valved femoral vein homograft. Now, I understand that in much of Asia there can be cultural problems with collecting a cardiac homograft. But I am very doubtful that there are cultural limitations on making a small incision in the thigh and collecting a segment of femoral vein. We find that femoral vein that usually tapers from around about 9 mm to 14 or 15 mm is a perfect size for neonatal repair operations that require a valved homograft conduit. We find that the vein tissue sutures very nicely. It's like suturing superior vena cava, but it has a valve in it. It doesn't require a hood, so that the proximal anastomosis is a simple one-stage anastomosis. And you can even use the same segment of homograft for your arch reconstruction because it's also ideal for the arch reconstruction in a Norwood or DKS-type approach.
So my second question is whether or not you've considered the possibility of using femoral vein rather than Gore-Tex, which I think must be very difficult in larger sizes, difficult in terms of getting a competent valve, and difficult to use because of rigidity, like a Hancock-type conduit. So what do you think about the possibility of collecting femoral veins? In the US they cost half of what a cardiac homograft costs and they're much more freely available.
Dr Nakano: As you know, in Japan the availability of a homograft is very limited. And if we could use a femoral vein homograft, currently our institutional policy is staging, because neonates are very vulnerable in terms of organ function, including the brain. We like to delay the extensive surgery beyond the neonatal period. And as I showed you in the slide, the postoperative course is much more stable in a staged group. So even if femoral vein homograft is available to us, we would prefer a staging strategy.
Dr Jonas: But do you think that it's technically possible for a group in Japan to start encouraging the collection of femoral veins? I'm always given this same answer when I mention this, "It's just not possible", but I have never been given an explanation as to what the cultural restriction is on collecting a femoral vein where the heart is left intact, there is no chest incision, it could even be done minimally invasively. So is there some cultural limitation to doing that?
Dr Nakano: Actually, personally, I cannot answer the question. I hope so, but I don't know.
Dr Jonas: I think in China and Japan and other Asian countries that have had trouble collecting cardiac homografts it really would be extremely helpful.
